Venetoclax and hypomethylating agents in critically ill patients with newly diagnosed acute myeloid leukaemia. Liang P, Xie Y, Liu Z, Wang D, et al. Br J Haematol 2024;204:1219-1226.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Liang P, Xie Y, Liu Z, Wang D, et al. Venetoclax and hypomethylating agents in critically ill patients with newly diagnosed acute myeloid leukaemia. Br J Haematol 2024;204:1219-1226.
PMID: 38180132